Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus

International Journal of Neuropsychopharmacology

Volumn 12, Issue 9, 2009, Pages 1209-1221

  Biggio, Francesca ^a,b   Gorini, Giorgio ^a   Utzeri, Cinzia ^a   Olla, Pierluigi ^a   Marrosu, Francesco ^a   Mocchetti, Italo ^b   Follesa, Paolo ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant drugs; gene expression; neurogenesis; neurotrophins; treatment resistant depression

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; BROXURIDINE; DOUBLECORTIN; IMIPRAMINE; ANXIOLYTIC AGENT; DOUBLECORTIN PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; NEUROPEPTIDE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC CELL; DENTATE GYRUS; HIPPOCAMPUS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MAZE TEST; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANQUILIZING ACTIVITY; VAGUS NERVE STIMULATION; ANIMAL; ANIMAL BEHAVIOR; ANIMAL MODEL; CYTOLOGY; DENDRITE; DRUG EFFECT; ELECTROSTIMULATION THERAPY; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME; VAGUS NERVE;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL PROLIFERATION; DENDRITES; DENTATE GYRUS; ELECTRIC STIMULATION THERAPY; HIPPOCAMPUS; IMIPRAMINE; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, ANIMAL; MOTOR ACTIVITY; NEURONAL PLASTICITY; NEURONS; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VAGUS NERVE;

EID: 79959362201     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145709000200     Document Type: Article

References (68)

1. Ben-Menachem E (2002). Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurology 1, 477-482 (Pubitemid 37159138)
2. Ben-Menachem E, Hamberger A, Hedner T, Hammond EJ, Uthman BM, Slater J, Treig T, Stefan H, Ramsay RE, Wernicke JF, et al. (1995). Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Research 20, 221-227
3. Ben-Menachem E, Manon-Espaillat R, Ristanovic R, Wilder BJ, Stefan H, Mirza W, Tarver WB, Wernicke JF (1994). Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia 35, 616-626 (Pubitemid 24217765)
4. Bohning DE, Lomarev MP, Denslow S, Nahas Z, Shastri A, George MS (2001). Feasibility of vagus nerve stimulation-synchronized blood oxygenation level-dependent functional MRI. Investigative Radiology 36, 470-479 (Pubitemid 32807722)
5. Bruel-Jungerman E, Rampon C, Laroche S (2007). Adult hippocampal neurogenesis, synaptic plasticity and memory: facts and hypotheses. Reviews in the Neurosciences 18, 93-114
6. Carlat DJ (2006). Vagus nerve stimulation and depression: conflict of interest's 'perfect storm'? Psychiatric Times 23, 14-15
7. Clark KB, Naritoku DK, Smith DC, Browning RA, Jensen RA (1999). Enhanced recognition memory following vagus nerve stimulation in human subjects. Nature Neuroscience 2, 94-98 (Pubitemid 30488946)
8. Coggeshall RE, Lekan HA (1996). Methods for determining numbers of cells and synapses: a case for more uniform standards of review. Journal of Comparative Neurology 364, 6-15 (Pubitemid 26026631)
9. Conway CR, Sheline YI, Chibnall JT, George MS, Fletcher JW, Mintun MA (2006). Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Research 146, 179-184
10. Couillard-Despres S, Winner B, Schaubeck S, Aigner R, Vroemen M, Weidner N, Bogdahn U, Winkler J, Kuhn HG, Aigner L (2005). Double cortin expression levels in adult brain reflect neurogenesis. European Journal of Neuroscience 21, 1-14 (Pubitemid 40193870)
11. Dazzi L, Ladu S, Spiga F, Vacca G, Rivano A, Pira L, Biggio G (2002a). Chronic treatment with imipramine or mirtazapine antagonizes stress- and FG7142-induced increase in cortical norepinephrine output in freely moving rats. Synapse 43, 70-77 (Pubitemid 33115669)
12. Dazzi L, Vignone V, Seu E, Ladu S, Vacca G, Biggio G (2002b). Inhibition by venlafaxine of the increase in norepinephrine output in rat prefrontal cortex elicited by acute stress or by the anxiogenic drug FG 7142. Journal of Psychopharmacology 16, 125-131 (Pubitemid 34614881)
13. Deacon RM, Rawlins JN (1996). Equithesin without chloral hydrate as an anaesthetic for rats. Psychopharmacology (Berlin) 124, 288-290
14. Dedeurwaerdere S, Cornelissen B, Van Laere K, Vonck K, Achten E, Slegers G, Boon P (2005a). Small animal positron emission tomography during vagus nerve stimulation in rats: a pilot study. Epilepsy Research 67, 133-141 (Pubitemid 41676822)
15. Dedeurwaerdere S, Cornelissen B, Van Laere K, Vonck K, Achten E, Slegers G, Boon P (2005b). Small animal positron emission tomography during vagus nerve stimulation in rats: a pilot study. Epilepsy Research 67, 133-141 (Pubitemid 41676822)
16. Dedeurwaerdere S, Vonck K, Claeys P, Van Hese P, D'Have M, Grisar T, Naritoku D, Boon P (2004). Acute vagus nerve stimulation does not suppress spike and wave discharges in genetic absence epilepsy rats from Strasbourg. Epilepsy Research 59, 191-198 (Pubitemid 38887690)
17. Dorr AE, Debonnel G (2006). Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. Journal of Pharmacology and Experimental Therapeutics 318, 890-898 (Pubitemid 44061265)
18. Duman RS (2005). Neurotrophic factors and regulation of mood: role of exercise diet and metabolism. Neurobiology of Aging 26 (Suppl. 1), 88-93
19. Duman RS, Heninger GR, Nestler EJ (1997). A molecular and cellular theory of depression. Archives of General Psychiatry 54, 597-606 (Pubitemid 27306570)
20. Duman RS, Monteggia LM (2006). A neurotrophic model for stress-related mood disorders. Biological Psychiatry 59, 1116-1127
21. Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE (2000). Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Research 42, 203-210
22. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH (1998). Neurogenesis in the adult human hippocampus. Nature Medicine 4, 1313-1317 (Pubitemid 28512114)
23. Follesa P, Biggio F, Gorini G, Caria S, Talani G, Dazzi L, Puligheddu M, Marrosu F, Biggio G (2007). Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain. Brain Research 1179, 28-34 (Pubitemid 47633509)
24. Follesa P, Porcu P, Sogliano C, Cinus M, Biggio F, Mancuso L, Mostallino MC, Paoletti AM, Purdy RH, Biggio G, Concas A (2002). Changes in GABAA receptor gamma 2 subunit gene expression induced by long-term administration of oral contraceptives in rats. Neuropharmacology 42, 325-336 (Pubitemid 34230485)
25. George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM, Howland R, Kling MA, Moreno F, Rittberg B, et al. (2005). A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biological Psychiatry 58, 364-373 (Pubitemid 41219704)
26. George MS, Sackeim HA (2008). Brain stimulation, revolutions, and the shifting time domain of depression. Biological Psychiatry 64, 447-448
27. George MS, Sackeim HA, Marangell LB, Husain MM, Nahas Z, Lisanby SH, Ballenger JC, Rush AJ (2000). Vagus nerve stimulation. A potential therapy for resistant depression? Psychiatric Clinics in North America 23, 757-783
28. Goodnick PJ, Rush AJ, George MS, Marangell LB, Sackeim HA (2001). Vagus nerve stimulation in depression. Expert Opinion in Pharmacotherapy 2, 1061-1063 (Pubitemid 32633707)
29. Handforth A, Krahl SE (2001). Suppression of harmaline-induced tremor in rats by vagus nerve stimulation. Movement Disorders 16, 84-88 (Pubitemid 36041118)
30. Harden CL (2002). The co-morbidity of depression and epilepsy: epidemiology, etiology, and treatment. Neurology 59 (6 Suppl. 4), S48-55
31. Harden CL, Pulver MC, Ravdin LD, Nikolov B, Halper JP, Labar DR (2000). A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behaviour 1, 93-99
32. Henry TR (2002). Therapeutic mechanisms of vagus nerve stimulation. Neurology 59 (6 Suppl. 4), S3-14
33. Henry TR, Bakay RA, Pennell PB, Epstein CM, Votaw JR (2004). Brain blood-flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: II. prolonged effects at high and low levels of stimulation. Epilepsia 45, 1064-1070 (Pubitemid 39238117)
34. Krahl SE, Clark KB, Smith DC, Browning RA (1998). Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 39, 709-714 (Pubitemid 28319506)
35. Krahl SE, Senanayake SS, Pekary AE, Sattin A (2004). Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. Journal of Psychiatric Research 38, 237-240 (Pubitemid 38299160)
36. Kuhn HG, Dickinson-Anson H, Gage FH (1996). Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. Journal of Neuroscience 16, 2027-2033 (Pubitemid 26144015)
37. Lipsky RH, Marini AM (2007). Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Annals of the New York Academy of Sciences 1122, 130-143 (Pubitemid 350249544)
38. Lomarev M, Denslow S, Nahas Z, Chae JH, George MS, Bohning DE (2002). Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. Journal of Psychiatric Research 36, 219-227 (Pubitemid 34626372)
39. Lurie P, Stine N (2006). Responding to three articles regarding vagus nerve stimulation (VNS) for depression. Biological Psychiatry 60, 1382; author reply 1382-1383 (Pubitemid 44838534)
40. Marrosu F, Serra A, Maleci A, Puligheddu M, Biggio G, Piga M (2003). Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy. Epilepsy Research 55, 59-70 (Pubitemid 37011373)
41. Milby AH, Halpern CH, Baltuch GH (2008). Vagus nerve stimulation for epilepsy and depression. Neurotherapeutics 5, 75-85 (Pubitemid 350299304)
42. Ming GL, Song H (2005). Adult neurogenesis in the mammalian central nervous system. Annual Review of Neuroscience 28, 223-250 (Pubitemid 41098905)
43. Nahas Z, Marangell LB, Husain MM, Rush AJ, Sackeim HA, Lisanby SH, Martinez JM, George MS (2005). Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. Journal of Clinical Psychiatry 66, 1097-1104 (Pubitemid 41442274)
44. Nibuya M, Morinobu S, Duman RS (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience 15, 7539-7547
45. Noldus LP, Spink AJ, Tegelenbosch RA (2001). EthoVision: a versatile video tracking system for automation of behavioral experiments. Behavioral Research Methods Instrument and Computers 33, 398-414 (Pubitemid 33594754)
46. Pardo JV, Sheikh SA, Schwindt GC, Lee JT, Kuskowski MA, Surerus C, Lewis SM, Abuzzahab FS, Adson DE, Rittberg BR (2008). Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism. NeuroImage 42, 879-889
47. Pare WP (1989). Stress ulcer susceptibility and depression in Wistar Kyoto (WKY) rats. Physiology & Behavior 46, 993-998 (Pubitemid 20012951)
48. Parent JM (2008). Persistent hippocampal neurogenesis and epilepsy. Epilepsia 49 (Suppl. 5), 1-2 (Pubitemid 351782994)
49. Paxinos G (1995). The Rat Nervous System. New York: Academic Press
50. Paxinos G, Watson C (1982). The Rat Brain in Stereotaxic Coordinates. New York: Academic Press
51. Pinheiro SN, Del-Ben CM, Zangrossi Jr. H, Graeff FG (2008). Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze. Journal of Psychopharmacology 22, 132-137 (Pubitemid 351322867)
52. Porsolt RD, Brossard G, Hautbois C, Roux S (2001). Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice. In: Crowley JN, McKay R, Rogawski (Eds), Current Protocols in Neuroscience (pp. 8.10A.1-8.10A.10). New York: Wiley & Sons
53. Porsolt RD, Le Pichon M, JalfreM(1977). Depression: a new animal model sensitive to antidepressant treatments. Nature 266, 730-732 (Pubitemid 8073804)
54. Raballo R, Rhee J, Lyn-Cook R, Leckman JF, Schwartz ML, Vaccarino FM (2000). Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex. Journal of Neuroscience 20, 5012-5023 (Pubitemid 30421705)
55. Rao MS, Shetty AK (2004). Efficacy of doublecortin as a marker to analyse the absolute number and dendritic growth of newly generated neurons in the adult dentate gyrus. European Journal of Neuroscience 19, 234-246 (Pubitemid 38177862)
56. Revesz D, Tjernstrom M, Ben-Menachem E, Thorlin T (2008). Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation. Experimental Neurology 214, 259-265
57. Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, Lavori P, Howland R, Kling MA, Rittberg B, et al. (2005). Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biological Psychiatry 58, 355-363 (Pubitemid 41219703)
58. Sackeim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z, Johnson CR, Seidman S, Giller C, Haines S, Simpson Jr. RK, Goodman RR (2001). Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 25, 713-728 (Pubitemid 32995954)
59. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805-809 (Pubitemid 36962615)
60. Schachter SC (2006). Therapeutic effects of vagus nerve stimulation in epilepsy and implications for sudden unexpected death in epilepsy. Clinical Autonomic Research 16, 29-32 (Pubitemid 43237899)
61. Schlaepfer TE, Frick C, Zobel A, Maier W, Heuser I, Bajbouj M, O'Keane V, Corcoran C, Adolfsson R, Trimble M, et al. (2008). Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychological Medicine 38, 651-661 (Pubitemid 351483238)
62. Schmidt HD, Duman RS (2007). The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behavioral Pharmacology 18, 391-418 (Pubitemid 47356367)
63. Sholl DA (1953). Dendritic organization in the neurons of the visual and motor cortices of the cat. Journal of Anatomy 87, 387-406
64. Teixeira RC, Zangrossi H, Graeff FG (2000). Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacology Biochemistry and Behavior 65, 571-576 (Pubitemid 30182498)
65. Wang JW, David DJ, Monckton JE, Battaglia F, Hen R (2008). Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. Journal of Neuroscience 28, 1374-1384 (Pubitemid 351231535)
66. Warner-Schmidt JL, Duman RS (2007). VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proceedings of the National Academy of Sciences USA 104, 4647-4652 (Pubitemid 47186279)
67. Wong ML, Licinio J (2001). Research and treatment approaches to depression. Nature Review Neuroscience 2, 343-351 (Pubitemid 33680576)
68. Zhao M, Li D, Shimazu K, Zhou YX, Lu B, Deng CX (2007). Fibroblast growth factor receptor-1 is required for long-term potentiation, memory consolidation, and neurogenesis. Biological Psychiatry 62, 381-390 (Pubitemid 47284024)